Applied Therapeutics (NASDAQ:APLT) Upgraded at Wall Street Zen
Applied Therapeutics (NASDAQ:APLT – Get Free Report) was upgraded by analysts at Wall Street Zen to a “sell” rating in a report issued on Thursday. Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $1.50 target price on shares of Applied Therapeutics in a report on Wednesday, May 14th. One equities […]
Applied Therapeutics (NASDAQ:APLT – Get Free Report) was upgraded by analysts at Wall Street Zen to a “sell” rating in a report issued on Thursday. Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $1.50 target price on shares of Applied Therapeutics in a report on Wednesday, May 14th. One equities […]
